The zinc-key — the registration plate

Zinc Thymulin: The Zinc-Dependent Activation of the Nonapeptide

One zinc ion is the difference between an inert peptide and an active hormone. The defining mechanistic fact, drawn out from the paper that coined the name.

The gist

Zinc thymulin is the switched-on version of the peptide. Thymulin (a small nine-amino-acid hormone from the thymus) needs exactly one zinc atom attached to do anything at all. With the zinc on, it folds into the right shape and works; with the zinc off, it is just an inert chain. Researchers proved this by stripping the zinc out with a chelator — a molecule that grabs metal ions — which killed the activity, then adding zinc back, which restored it. That is why zinc thymulin, and zinc status generally, sit at the center of every other thymulin finding.

Is thymulin the same as serum thymic factor (FTS)?

Zinc thymulin is the zinc-bound, biologically active form of serum thymic factor (FTS, facteur thymique serique) [1]. The zinc-free apopeptide is inactive; binding one zinc ion converts FTS into active thymulin [1]. So "FTS" and "thymulin" name the same nine-residue chain — the difference is whether the zinc is on. Older papers using "FTS" or "FTS-Zn" are describing this molecule [1].

What is the amino acid sequence of thymulin?

Thymulin is the nonapeptide pyroGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn — written in shorthand as <Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn — with molecular formula C33H54N12O15 and a molecular weight of 858.86 Da [1][3]. It is active only when bound to zinc in a 1:1 molar ratio [3]. The N-terminal pyroglutamate (the <Glu notation) is a cyclized glutamate residue, a common feature that caps the chain's front end.

Why does thymulin need zinc to work?

Zinc binding gives the peptide its active conformation. Dardenne and colleagues demonstrated the dependence head-on: treating serum thymic factor with the chelator Chelex 100 abolished its biological activity in the rosette assay, and activity was restored by zinc salts — and, to a lesser extent, a few other metals — with a 1:1 metal-to-peptide ratio giving optimal activation [1]. They confirmed the metal content by atomic absorption spectrometry and named the zinc-bound active form thymulin [1].

The structural reason is shape. The zinc-bound peptide adopts a specific three-dimensional conformation detectable by NMR; the apopeptide does not hold that shape, and so it cannot act [3]. This is why zinc-dependence is the defining mechanistic fact of thymulin, not a footnote: chelate the zinc and the molecule goes dark; restore equimolar zinc and the activity returns [1]. Every downstream effect — thymulin and immune function, the anti-inflammatory signaling, the neuroendocrine role — rides on the zinc being in place.

Zinc status, aging, and thymulin activity in humans

Because the active form requires zinc, serum thymulin activity tracks zinc status — and Prasad and colleagues showed this in people. Across three models of mild human zinc deficiency (two dietary-restriction volunteers, plus six sickle-cell-anemia and six non-SCA adults), serum thymulin activity was decreased despite normal plasma zinc and was corrected by in-vivo and in-vitro zinc supplementation, alongside reversible shifts in T-cell subsets and IL-2 activity [5]. Dardenne and Pleau likewise positioned serum thymulin activity as a sensitive indicator of zinc status, correctable by zinc supplementation in animals and humans [3].

Aging compounds the picture. Circulating thymulin declines with age, and zinc availability often declines with it — in part because zinc-binding proteins such as metallothionein, elevated in aging, may sequester zinc away from the peptide [3]. This is why zinc thymulin is discussed so often in the same breath as immunosenescence: when zinc runs short, the activation step runs short, and the peptide's message goes partly unread [5].

Zinc as the activation step, not a substitute for thymulin

One caution the literature itself raises: because activity is strictly zinc-dependent, reported thymulin effects are entangled with zinc status, which complicates attributing any outcome to the peptide alone [6]. Zinc enables thymulin; it does not replace it. The closest supplementation context to thymulin is therefore zinc — not because zinc is thymulin, but because zinc is the switch that the body's existing thymulin needs [3]. That distinction matters when reading any consumer framing of a "thymulin supplement."